Physician profile
Jennifer E Mcdaniel
NPI 1861784910
$1,187.75
in general payments reported to CMS, 2019-2025
16 companies · $561 in 2025
The $561 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.22 · 2022: $50.79 · 2023: $269 · 2024: $294 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,123.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $421.67 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $220.36 | 2023-2024 | Sotyktu |
| Janssen Biotech, INC. | $149.16 | 2025 | Tremfya |
| Pfizer INC. | $87.93 | 2022-2025 | |
| Boston Scientific Corporation | $57.17 | 2024 | Watchman Flx |
| Lilly USA, LLC | $41.29 | 2024-2025 | Omvoh, Zepbound |
| Regeneron Healthcare Solutions, INC. | $39.51 | 2025 | Dupixent |
| Ardelyx, INC. | $30.51 | 2025 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $25.43 | 2022 | |
| Braintree Laboratories, INC. | $19.36 | 2025 | Sutab, Suflave |
| Aimmune Therapeutics, INC. | $18.15 | 2025 | Zenpep |
| Madrigal Pharmaceuticals | $17.74 | 2025 | Rezdiffra |
| Abbott Laboratories | $17.39 | 2023 | Freestyle Libre 3 |
| Ipsen Biopharmaceuticals, INC | $14.26 | 2025 | Iqirvo |
| Coopersurgical, INC. | $14.06 | 2025 | Insorb |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $13.76 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.